GLP-1 RAs are medications that work the same way as the natural GLP-1 hormone to help regulate blood sugar and support weight control
Obeid R, et al
The main compound patent protecting the active ingredient semaglutide as used in these three drugs is set to expire in December 2031
Methods: We created a new clinical assessment tool using available national guidance from national patient safety advisory and WHO check list to monitor safe NG placement alongside x-ray
Switching back to mammalian models (hamster, rats, pigs), researchers found that GLP-1 could stimulate insulin secretion and inhibit glucagon release, which could vastly benefit diabetic patients
The Wegovy prescribing information lists nausea, diarrhea, vomiting, constipation, and abdominal pain among common adverse reactions, and many GLP-1 nutrition resources recommend gentler textures and smaller servings